1470nm Laser for the Treatment of Androgenetic Alopecia and Scarring Alopecia
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-99
SponsorMontefiore Medical Center
About this trial
Single-center, open-label, baseline-controlled, pilot study evaluating the use of a Nonablative 1470 nm laser for the treatment of androgenetic alopecia and scarring alopecia.
Eligibility criteria
Qualifiers
Healthy males and females, ≥ 18 years of age at time of informed consent, seeking treatment for hair loss
Subject must voluntarily sign and date an IRB approved informed consent form
Subjects with diagnosis of biopsy proven androgenetic alopecia or scarring alopecia with hair loss recorded over the past 6 months
Subjects must have a stable hair loss treatment regimen with a plateau in results for at least 3 months
Disqualifiers
Subject does not have the capacity to consent to the study
Subject has other types of alopecia of the scalp like alopecia areata
History of intralesional steroid injections to the scalp in the last 12 months
Pregnant women
Trial design
Treatments tested in this trial
- Sciton HALO 1470nm Non-ablative laser
Treatment groups
10 Participants
are divided into 2 treatment groupsSponsors and collaborators
Montefiore Medical Center
Lead sponsor
Sciton
Collaborator
Source ClinicalTrials.gov